Navigation Links
Qforma Appoints Four Executives in Sales and Field Operations
Date:6/25/2009

SANTA FE, N.M., June 25 /PRNewswire/ -- Qforma, an advanced analytics and predictive modeling company, today announced the appointments of four executives to sales and field operations positions: Mark J. Grove is appointed Senior Vice President, Sales, New Business; Dean H. Kleyn advances within Qforma from Director, Field Operations to Vice President, Sales and Services; and Rod Anaforian and Kim Foster join Qforma as Directors, Field Operations.

These appointments follow a series of important milestones for Qforma in 2009, highlighted by the launch in May of the "Most Influential Doctors" (MID) database, a new quarterly health feature developed by Qforma and presented by USA TODAY that for the first time provides consumers with access to valuable information about the top healthcare providers in virtually every U.S. metropolitan area.

"This is an exciting, transformational time for Qforma and we are pleased with our continued growth and the increased interest in our technology, products and expertise," said Kelly D. Myers, CEO of Qforma. "Most of all we are proud of the high caliber of professionalism that Qforma is able to bring to our customers, as represented by these four experienced and extremely talented individuals."

Mark J. Grove has held multiple sales positions over the course of his career in the healthcare industry, with a proven record of exceeding goals and advancing to positions of increasing responsibility at such companies as Tyco International, IMS Health, and Concord Management Group. He most recently served as Executive Vice President at Healthy Advice Networks.

Dean H. Kleyn brings to his new position within Qforma more than 15 years of sales, data integrity, advanced analytics, market research and software services experience in the pharmaceutical and biotech industries, enhanced by several years in the health care financing sector.

Rod Anaforian joins Qforma following a diverse 25-year career in pharmaceutical sales, sales training and field sales management in addition to experience as the chief operating officer for a large regional commercial property and asset management firm.

Kim Foster began her career in the pharmaceutical data industry at NDC Health (now Wolters Kluwer Health), where she held a series of positions of increasing responsibility. Most recently, Kim worked as an independent contractor on data analysis and programming projects for ArcLight Systems.

About Qforma

Qforma is an advanced analytics and predictive modeling company specializing in solutions for the pharmaceutical and biotech industries. Qforma leverages the talents of physicists, mathematicians and programmers, and has developed a unique approach to quantifying large data flows with the purpose of eliminating the inefficiencies of traditional sales and marketing techniques. In May 2009, Qforma launched "Most Influential Doctors" (MID), a first-of-its-kind online database presented by USA TODAY that provides consumers with information about the top community medical leaders in virtually every metropolitan area in the U.S. The database is available at www.influentialdoctors.usatoday.com.

Qforma is headquartered in Santa Fe, NM, with offices in: Boston, MA; Bucks County, PA; and Princeton, NJ. More information is located at http://www.Qforma.com.

    Media Contacts:
    Lisa Haley, Qforma
    (505) 603-7596
    lhaley@qforma.com

    Jeff Hoyak, MCS Healthcare Public Relations
    (800) 477-9626, ext. 312
    jeffh@mcspr.com


'/>"/>
SOURCE Qforma
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Qforma Appoints Two New Executives
2. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
3. Codexis Appoints Singapore Laboratories Managing Director
4. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
5. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
6. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
7. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
8. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
9. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
10. NeurogesX Appoints New Director to the Board
11. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... The Fight Against Cancer Innovation Trust (FACIT) and the ... report that Fusion Pharmaceuticals Inc. (Fusion) has closed a ... – JJDC, Inc. (JJDC) as the lead investor. Additional, ... and Genesys Capital, as well as founding investor FACIT.  ... ...
(Date:2/23/2017)... , Feb. 23, 2017  In Atlanta, it seems ... fashion, and culture intertwine to create an expressive and dynamic ... reflect this energy and contribute to it. ... Hair Fairies seeks to carry on that tradition ... Atlanta salon is the newest of ...
(Date:2/23/2017)... , Feb. 23, 2017  Imanis Life ... product line of oncolytic vaccinia viruses for virotherapy ... as part of Genelux,s proprietary, vaccinia virus-based technology ... excited to enter into a partnership with Genelux ... oncolytic vaccinia viruses for use in research," said ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... that in a published evaluation of multiple immunoassay-based threat detection technologies by ... Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found to have ...
Breaking Biology Technology:
(Date:2/7/2017)... MINNETONKA, Minn. , Feb. 7, 2017   ... that supports the entire spectrum of clinical research, is ... iMedNet , its innovative, highly flexible and ... iMedNet customers. iMedNet is a ... only provides Electronic Data Capture (EDC), but also delivers ...
(Date:2/3/2017)... Feb. 3, 2017 A new independent identity ... Partners, LLP (IdSP) . Designed to fill a critical ... identity market, founding partners Mark Crego and ... years just in identity expertise that span federal governments, ... leadership. The Crego-Kephart combined expertise has a common theme ...
(Date:1/31/2017)... CAMBRIDGE, Mass. , Jan. 31, 2017 /PRNewswire-USNewswire/ ... develop novel therapies for the treatment of bacterial ... generation set of antibacterial candidates from Pro Bono ... the increased prevalence of multi-drug resistant forms of ... by Cantab Anti Infectives Ltd, a PBB group ...
Breaking Biology News(10 mins):